*Some Market data delayed by 15 mins.

BioVie, Inc. Common Stock

Symbol: BIVI (NASDAQ)
0.47 ▲ (1.50%) 0.007

Company Description:
BioVie Inc is a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Key Stats
  • Today's Open: $0.46
  • Today's High: $0.471
  • Today's Low: $0.441
  • Today's Volume: 530.11K
  • Yesterday Close: $0.4601
  • Yesterday High: $0.49
  • Yesterday Low: $0.453
  • Yesterday Volume: 268.20K
  • Last Min Volume: 2.29K
  • Last Min High: $0.468
  • Last Min Low: $0.467
  • Last Min VWAP: $0.468
Company Profile
  • Name: BioVie, Inc. Common Stock
  • Website: https://www.bioviepharma.com
  • Listed Date: 2014-01-14
  • Location: CARSON CITY, NV
  • Market Status: Active
  • CIK Number: 0001580149
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $28.35M
  • Round Lot: 100
  • Outstanding Shares: 60.97M
  • Asset Type: CS
RECENT FILINGS FOR BIVI
Filing DateFiling TypeFormat
2024-06-07PRE 14AView
2024-05-1410-QView
2024-04-198-KView
2024-04-05UPLOADView
2024-03-15CORRESPView
2024-03-13UPLOADView
2024-03-118-KView
2024-03-064View
2024-03-068-KView
2024-03-048-K/AView
2024-03-04424B5View
2024-03-048-KView
2024-03-01424B5View
2024-03-018-KView
2024-02-1310-QView
2024-01-258-KView
2024-01-198-KView
2024-01-19424B3View
2023-12-134View
2023-12-064View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.